APAC / Prestige & HH&L IPO News; Cold Chain Vaccine Challenges; Moderna Looks to CMOs
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L…
Top Stories
JP Morgan 2021 / A Course Correction for Future Meetings
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual format, noting potential changes in format for future events. Crean does,…
USA / What to Expect if Janet Woodcock Becomes Permanent FDA Head
Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr Janet Woodcock was named as acting…
Population Health / Deloitte Global Healthcare Leader on COVID-19 Vaccine Challenges
Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19…
Vaccines / Top 4 Global Companies
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines.…
LatAm / Vaccination Challenges; Colombian COVID Variant; Pfizer’s Peru Problem
The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national…
Exclusive / Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche Oncology Focus & More
In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical…
In Conversation
Geert Van Hoof – General Manager, Chiesi Belgium
Geert Van Hoof, founding general manager of Chiesi Belgium, shares the exciting milestones of the company’s first decade in Belgium, including their stunning year-on-year double-digit growth, their market leadership in respiratory as well as neonatology, and their growing presence in rare diseases, as well as the attractiveness of the Chiesi Culture to potential employees in Belgium. The Chiesi Culture…
Latest Reports
Focus on China
China: Sinopharm Vaccine Approval; Online Healthcare Boom;…
The latest from Chinese pharma, including domestic regulatory approval for…
5 Top Trends in Chinese Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but…
Chinese Pharma Share Price Hit; Pfizer-LianBio Linkup;…
The latest from Chinese pharma, including a drop in share prices for Chinese…
2020’s Top 7 Biotech IPOs in Profile
Following the recent news of Remegen's massive USD 515 million IPO in November…
Read more: China >>
Focus on Norway
Norway: Staking a Claim as a Pharma Research Hub
Norway, more well-known internationally as an innovation hub for oil & gas…
Norway: Ahead of the Curve on Digitalisation
Many countries have struggled to adapt to the shift to remote working and…
Photocure: Swimming in the “Blue Ocean” of Oncology…
Photodynamic therapy (PDT) firm Photocure is probably Norway’s most…
Norwegian Neuroscience: Nobel Prizes & Enduring Focus
Norway has long held a strong international position in neuroscience and is home…
Read more: Norway >>
Focus on USA
JP Morgan 2021 Virtual Healthcare Conference: A Course…
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare…
What to Expect if Janet Woodcock Becomes Permanent FDA Head
Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr…
The Long Read: Innovation, Access & Affordability in…
A Tale of Two Americas The US stands as the biopharma innovation champion of…
The Value Proposition of Generics & Biosimilars in the…
AAM President Dan Leonard highlights the findings of the association’s most…
Read more: USA >>
Focus on MEA
5 Saudi Arabian Pharma Companies to Know
Following on from our list of the overall top 10 companies in the Saudi Arabian…
COVID-19 / Lessons from MSD’s Ebola Vaccine Development:…
While outbreaks of the devastating Ebola virus have – thankfully – generally…
MEA Roundup: Turkey’s Pharma Debt; Saudi Market Rise; UAE…
A roundup of the latest from the Middle East & Africa region, including…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
Read more: MEA >>
Focus on Vaccines
Securing Trust in the COVID-19 Supply Chain: From…
Scientists have come together in an unparalleled worldwide collaboration and…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
LatAm: Vaccination Challenges; Colombian COVID Variant;…
The latest news from pharma and healthcare in Latin America, including funding…
Top 4 Global Vaccine Companies
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of…
Read more: Vaccines >>
Focus on Europe
Cross Country Collaborations in Europe: The Future of…
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland…
Norwegian Neuroscience: Nobel Prizes & Enduring Focus
Norway has long held a strong international position in neuroscience and is home…
The Pharmaceutical Strategy for Europe – A Game-Changer…
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy…
Can Sweden take the lead in Precision Medicine?
Anders Blanck of Lif, the trade association for the research-based Swedish…
Read more: Europe >>
Focus on Switzerland
Why Switzerland Needs a US FTA to Stop it ‘Falling Through…
The USA is now Switzerland’s biggest export market and in 2019 Switzerland…
Market Access in Switzerland: Reimbursement Delays for 76%…
Switzerland, rightly regarded as one of the world’s most innovative nations,…
What Three Pharma Leaders Want to Share About Switzerland
PharmaBoardroom highlights three of the most enterprising and dynamic pharma…
Post-Brexit UK Joins Australia, Canada, Singapore &…
When the European Medicines Agency (EMA) relocated from London to Amsterdam…
Read more: Switzerland >>
Focus on Singapore
APAC: Prestige & HH&L IPO News; Cold Chain Vaccine…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for…
Post-Brexit UK Joins Australia, Canada, Singapore &…
When the European Medicines Agency (EMA) relocated from London to Amsterdam…
Southeast Asia: Singapore Pharma Production Surge;…
The latest from Southeast Asian pharma, including soaring output in Singapore,…
Singapore Pharma Exports Rise as Global API Demand Surges
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its…